Navigation Links
BioLineRx Presents Data on BL-1040 at Cardiovascular,Revascularization Therapies Conference Demonstrating Potential to,Reduce Deterioration of Infarcted Heart Tissue and Maintain,Functionality

ties and biotech companies to further the commercialization of promising compounds, BioLineRx seeks to enrich the pipeline of large pharmaceutical companies seeking their next blockbuster drugs. The Company was founded in 2003 by leaders in the Israeli life science arena including Teva Pharmaceuticals Ltd, Giza, Pitango, Hadasit and the Jerusalem Development Authority. For more information, please visit www.biolinerx.com.

Contact

BioLineRx Ltd.
Yuri Shoshan, +972-2-548-9100
VP Finance and Corporate Development
yuri@biolinerx.com
or
Media Liaison, BioLineRx Ltd.
Tsipi Haitovsky, +972-52-598-9892
tsipih@biolinerx.com
or
Stern Investor Relations, Inc.
Melanie Friedman, 212-362-1200
melanie@sternir.com


'"/>




Page: 1 2 3

Related medicine technology :

1. BioLineRx Presents Data From Successful Phase I Trial for BL-1020 in Schizophrenia at American Psychiatric Association Conference
2. BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming Clinical Conferences
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
5. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
6. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
7. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
8. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
9. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
10. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
11. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting

Post Your Comments:
(Date:11/23/2009)...wire-FirstCall/--Amgen(Nasdaq: AMGN )washonoredwit...ndforBestNewDrugforNplate®(romiplostim),ataNo...awardwaspresentedtoAmgenbyScripinrecognitionofthes...spipeline,aswellasitsmixofcandidatesacrossdevelopm...tableforitsfocusonunmetclinicalneed. ,, "Wearev...
(Date:11/23/2009)...tlinker.comannouncesthatanewmarketresearchreportis...ndEMR ,, http://www.reportlinker.com/p016474...swire&utm_medium=pr&utm_campaign=prnewswir...st$1.3billion,representinganincreaseof6.7%over2007...iumhospitals(201-499beds),communityhospitals(200be...
(Date:11/23/2009)...tlinker.comannouncesthatanewmarketresearchreportis...stems-AGlobalMarketReview ,, http://www.repo...A-Global-Market-Review.html#utm_source=prnewswire&...,, Cardiovascularmonitoringisextremelybeneficia...nuouslymonitoredduringdiagnosticaswellaspatientcar...
Breaking Medicine Technology:Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 3Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 4Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 5Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 6Reportlinker Adds U.S. Market for PACS and EMR 2Reportlinker Adds U.S. Market for PACS and EMR 3Reportlinker Adds U.S. Market for PACS and EMR 4Reportlinker Adds U.S. Market for PACS and EMR 5Reportlinker Adds U.S. Market for PACS and EMR 6Reportlinker Adds U.S. Market for PACS and EMR 7Reportlinker Adds U.S. Market for PACS and EMR 8Reportlinker Adds U.S. Market for PACS and EMR 9Reportlinker Adds U.S. Market for PACS and EMR 10Reportlinker Adds U.S. Market for PACS and EMR 11Reportlinker Adds U.S. Market for PACS and EMR 12Reportlinker Adds U.S. Market for PACS and EMR 13Reportlinker Adds Holter Monitoring Systems - A Global Market Review 2Reportlinker Adds Holter Monitoring Systems - A Global Market Review 3Reportlinker Adds Holter Monitoring Systems - A Global Market Review 4Reportlinker Adds Holter Monitoring Systems - A Global Market Review 5Lilly Surpasses United Way 2009 Campaign Goal 6272 1Lilly Surpasses United Way 2009 Campaign Goal 6272 2Lilly Surpasses United Way 2009 Campaign Goal 6272 3Dishler Laser Institute Announces Dr Jon Dishler Selected as a Leading Laser Eye Surgeon of the United States as Seen in Forbes Magazine 61406 1Dishler Laser Institute Announces Dr Jon Dishler Selected as a Leading Laser Eye Surgeon of the United States as Seen in Forbes Magazine 61406 2SCM Microsystems Reports Third Quarter 2009 Results 10727 1SCM Microsystems Reports Third Quarter 2009 Results 10727 2SCM Microsystems Reports Third Quarter 2009 Results 10727 3SCM Microsystems Reports Third Quarter 2009 Results 10727 4SCM Microsystems Reports Third Quarter 2009 Results 10727 5SCM Microsystems Reports Third Quarter 2009 Results 10727 6SCM Microsystems Reports Third Quarter 2009 Results 10727 7SCM Microsystems Reports Third Quarter 2009 Results 10727 8SCM Microsystems Reports Third Quarter 2009 Results 10727 9SCM Microsystems Reports Third Quarter 2009 Results 10727 10SCM Microsystems Reports Third Quarter 2009 Results 10727 11SCM Microsystems Reports Third Quarter 2009 Results 10727 12
.../Webcast at 8:30 a.m. EDT on May 29 -, SOMERSET, ...) today announced that the preliminary statistical... clinical trial of its lead compound,ONCONASE (ran...r the,primary endpoint of survival in unresectable...cally significant improvement in survival was seen...
...em plays key role in discovery, ITASCA, Ill. and ...n 10,000 patients, conducted by the Universities o...g AtCor Medical Holdings,Limited,s SphygmoCor(R) h...ntified as having "high normal" systolic blood pre...urement may be at serious,cardiovascular risk. Thi...
Other Medicine Technology:Alfacell Corporation Announces Preliminary Results From ONCONASE(R) Phase IIIb Clinical Trial 2Alfacell Corporation Announces Preliminary Results From ONCONASE(R) Phase IIIb Clinical Trial 3Alfacell Corporation Announces Preliminary Results From ONCONASE(R) Phase IIIb Clinical Trial 4Alfacell Corporation Announces Preliminary Results From ONCONASE(R) Phase IIIb Clinical Trial 5New Study Linking 'High Normal' Blood Pressure to Significant Cardiovascular Risk 2New Study Linking 'High Normal' Blood Pressure to Significant Cardiovascular Risk 3
(Date:11/23/2009)...ght ease the problem, researchers say , ,...le up their anger over unfair treatment at work co...ndicates. , Men who consistently failed to expr...worker or supervisor were more than twice as likel...s those who vented their anger, claims a report in...
(Date:11/23/2009)...vidualsintheRecommendedPriorityGroups ,, HARRIS...tmentofHealthannouncedtodaytheywillconductthreeadd...tersinDelaware,Lancaster,andLehighcountiesonTuesda...dministeredforfreetoindividualsintherecommendedtar...Thedepartmentasksthatonlyindividualsinthefollowing...
(Date:11/23/2009)... and survivors treated with chemotherapy suffer in...c conditions, hindering patients, ability to fully...y of Rochester Medical Center. , A study of 823 ...bles at nearly three times the rate of the general...nger patients and those with lung and breast cance...
(Date:11/23/2009)...st-of-its-kind consensus statement on diabetes sur...urgery . The report illustrates the findings of th...etes Surgery Summit (DSS) -- where an internationa...erts agreed on a set of evidence-based guidelines ...d study of gastrointestinal surgery to treat type ...
(Date:11/23/2009)...ents who reined in their hypertension, study found...-- High blood pressure is better controlled by doc...doctors and pharmacists working alone, a new study...s, medications are intensified, dosages increased,... Carter, a professor in the University of Iowa Col...
Breaking Medicine News(10 mins):Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 2Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 3Health News:Pennsylvania Department of Health Announces Additional H1N1 Vaccination Clinics in Delaware, Lancaster, Lehigh Counties 2Health News:Insomnia prevalent among cancer patients who receive chemotherapy 2Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 2Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 3Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 4Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 5Health News:Doctor-Pharmacist Teams Boost Blood Pressure Control 2Health News:Doctor-Pharmacist Teams Boost Blood Pressure Control 3
..., Pa., Feb. 11 The Office of,Administration today... to,March 21 for retired state employees to select...ective on May 1., "We understand choosing a healt...ry of Administration Naomi Wyatt said.,"Therefore,...
...GE, Mass.--A new thin-film coating developed at MI...rgets in the body following implantation, essentia... eventually be used to deliver drugs for cancer, e..., You can mete out what is needed, exactly when i...
...1 million, Five-year Grant, from New York State De...ntamination before Child Becomes Lead,Poisoned, N... Prevention Program at The Children,s Hospital at ...ren and,pregnant women with elevated blood lead le...
...d to hundreds of allergic reactions and possibly 4...lthDay News) -- Baxter HealthCare Corp., which pro...e United States, said Monday that it was temporari...s. , The cause of the allergic reactions isn,t kno...
..., Fla., Feb. 11 Lincare Holdings,Inc. (Nasdaq: L...iratory,therapy services delivered to patients in ...e fourth quarter and year ended December 31, 2007....06. The Company estimates that the increase in net...
...olled hypertension rates in men and women vary acr... south and including the nations capital should b...eport in Circulation: Journal of the American Hear...mination clinic (MEC) and averaged. The first mea...
Other Medicine News:Health News:Office of Administration Extends Retired State Employees Health Benefits Enrollment Period to March 21 2Health News:MIT develops thin-film 'micro pharmacy' 2Health News:Montefiore Lead Poisoning Prevention ProgramNamed One of Three State Regional Resource Centers 2Health News:Manufacturer Halts Production of Blood Thinner Heparin 2Health News:Manufacturer Halts Production of Blood Thinner Heparin 3Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2007 Financial Results 2Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2007 Financial Results 3Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2007 Financial Results 4Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2007 Financial Results 5Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2007 Financial Results 6Health News:Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2007 Financial Results 7Health News:High blood pressure worsening in all states for women; begins to stagnate for men 2Health News:High blood pressure worsening in all states for women; begins to stagnate for men 3
...in conjunction with the Vortex Genie 2 for rapid b...dapter is an inexpensive alternative to other bead...me technology. This particular adapter holds 4 (1...y Vortex Genie 2 with a 3 inch platform attachment...
Vortex Adapter for Vortex Genie 2, holds (12) 2 ml tubes
...Vacuum Controller V-800 and water-cooled secondary...om Compact Housing Model V-500 is a powerful P...acuum applications. Applications Ideally suited...atory vacuum source for instruments including vacu...
...Vacuum Controller V-800 and water-cooled secondary...om Model V-500 is a powerful PTFE membrane vacu...s. Applications Ideally suited for use with up ...ce for instruments including vacuum ovens, concent...
Medicine Products: